Dr. Shirish Gadgeel, MD
Claim this profileHenry Ford Hospital
Studies Non-Small Cell Lung Cancer
Studies Tumors
17 reported clinical trials
28 drugs studied
About Shirish Gadgeel, MD
Education:
- Received an MD (Doctor of Medicine) from the University of Bombay, India, in 1987.
Experience:
- Serves as a Clinical Professor of Oncology at Wayne State University School of Medicine.
- Holds the position of Chief of Thoracic Oncology at the Henry Ford Cancer Institute.
- Acts as the Director of the Thoracic Oncology Research Program at the Henry Ford Cancer Institute.
Area of expertise
1Non-Small Cell Lung Cancer
KRAS positive
Stage IV
PD-L1 positive
2Tumors
Stage IV
Stage III
HER2 positive
Affiliated Hospitals
Clinical Trials Shirish Gadgeel, MD is currently running
Adagrasib Combo Therapy
for Lung Cancer
Study CA239-0010 is an open-label, Phase 2 clinical trial evaluating the clinical efficacy of adagrasib in combination with pembrolizumab and chemotherapy in the first-line setting for patients with advanced NSCLC with TPS ≥ 1%, TPS \<50% and KRAS G12C mutation
Recruiting1 award Phase 24 criteria
CAB-AXL-ADC + PD-1 Inhibitor
for Lung Cancer
The objective of this study is to assess safety and efficacy of CAB-AXL-ADC in NSCLC
Recruiting1 award Phase 27 criteria
More about Shirish Gadgeel, MD
Clinical Trial Related3 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Shirish Gadgeel, MD has experience with
- Pembrolizumab
- Pemetrexed
- Carboplatin
- Avutometinib (VS-6766)
- TPX-0022
- Telaglenastat
Breakdown of trials Shirish Gadgeel, MD has run
Non-Small Cell Lung Cancer
Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Shirish Gadgeel, MD specialize in?
Shirish Gadgeel, MD focuses on Non-Small Cell Lung Cancer and Tumors. In particular, much of their work with Non-Small Cell Lung Cancer has involved KRAS positive patients, or patients who are Stage IV.
Is Shirish Gadgeel, MD currently recruiting for clinical trials?
Yes, Shirish Gadgeel, MD is currently recruiting for 10 clinical trials in Detroit Michigan. If you're interested in participating, you should apply.
Are there any treatments that Shirish Gadgeel, MD has studied deeply?
Yes, Shirish Gadgeel, MD has studied treatments such as Pembrolizumab, Pemetrexed, Carboplatin.
What is the best way to schedule an appointment with Shirish Gadgeel, MD?
Apply for one of the trials that Shirish Gadgeel, MD is conducting.
What is the office address of Shirish Gadgeel, MD?
The office of Shirish Gadgeel, MD is located at: Henry Ford Hospital, Detroit, Michigan 48202 United States. This is the address for their practice at the Henry Ford Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.